Dataset from A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients

This study is a randomized, open label clinical trial to evaluate the safety and efficacy of
hydroxychloroquine (HCQ) plus usual care compared to usual care in approximately 350
hospitalized patients diagnosed with COVID-19. The study will be a 2-arm, non-blinded
comparison between open label hydroxychloroquine and usual care. The course of treatment
(HCQ) is five days. Participants will be followed to study day 28.